1-20 of 49
Peter L. Turecek
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Irish Personalized Approach to the Treatment of Haemophilia (iPATH) - Determinants of Inter-Individual Variation in FVIII Pharmacokinetics

Michelle Lavin, MB, PhD FRCPath, Niamh Larkin, Anjali Patel, Evelyn Singleton, Mary Byrne, Kevin Ryan, MB, FRCPath, Niamh M O'Connell, MB, PhD FRCPath, Birgit M Reipert, Steven Pipe, Peter L Turecek, PhD, James S O'Donnell, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1190.
https://doi.org/10.1182/blood-2018-99-112850
Published: 2018
Journal Articles

Polyethylene Glycol (PEG) Exposure in Parenteral Therapies Indicated for the Pediatric Population: History and Safety

Reinhard Stidl, PhD, Elizabeth Schwartz, PhD, Michael Denne, PharmD, Jimena Goldstine, PhD, Bill Kadish, MD, Katherine I. Korakas, PhD, Peter L. Turecek, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3666.
https://doi.org/10.1182/blood.V130.Suppl_1.3666.3666
Published: 2017
Journal Articles

Nonclinical Safety of SHP 826 (BAX 826), a Next Generation Extended Half-Life Recombinant Factor VIII Product

Veronika Ehrlich, Peter Leidenmuehler, Barbara Dietrich, Gerald Hoebarth, Tanja Ruthsatz, Peter L. Turecek, PhD, Martin Wolfsegger, Cstat (RSS), Alfred Weber, Herbert Gritsch, Werner Hoellriegl, Marietta Turecek
Journal: Blood
Blood (2016) 128 (22): 4977.
https://doi.org/10.1182/blood.V128.22.4977.4977
Published: 2016
Journal Articles

Nonclinical Assessment of Bax 604 (FEIBA STAR) - Reduced Volume Reconstitution & Higher Infusion Rate

Gerald Hoebarth, Alexandra Kopic, Martin Wolfsegger, Cstat (RSS), Alexander Bauer, Peter L. Turecek, PhD, Peter Leidenmuehler, Karima Benamara, Werner Hoellriegl, Marietta Turecek
Journal: Blood
Blood (2016) 128 (22): 2590.
https://doi.org/10.1182/blood.V128.22.2590.2590
Published: 2016
Journal Articles

Low ADAMTS13 activity is associated with an increased risk of ischemic stroke

Clinical Trials & Observations
Michelle A. H. Sonneveld, Moniek P. M. de Maat, Marileen L. P. Portegies, Maryam Kavousi, Albert Hofman, Peter L. Turecek, Hanspeter Rottensteiner, Fritz Scheiflinger, Peter J. Koudstaal, M. Arfan Ikram, Frank W. G. Leebeek
Journal: Blood
Blood (2015) 126 (25): 2739–2746.
https://doi.org/10.1182/blood-2015-05-643338
Published: 2015
Includes: Supplemental data
Journal Articles

Development of BAX 826, a Polysialylated Full-Length rFVIII with Significantly Improved PK Properties

Peter L. Turecek, PhD, Juergen Siekmann, PhD, Artur Mitterer, PhD, Michael Graninger, PhD, Gerald Schrenk, PhD, Peter Matthiessen, PhD, Hanspeter Rottensteiner, PhD, Werner Hoellriegl, DVM, Marietta Putz, MS, Hans Peter Schwarz, MD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2015) 126 (23): 3536.
https://doi.org/10.1182/blood.V126.23.3536.3536
Published: 2015
Journal Articles

Pharmacokinetics of BAX 826, a Polysialylated Full-Length rFVIII, in Hemophilia a Mice, Rats, and Cynomolgus Monkeys

Alexandra Schiviz, DVM, Gerald Hoebarth, Martin Wolfsegger, Paolo Rossato, Alfred Weber, Herbert Gritsch, Hanspeter Rottensteiner, PhD, Peter L. Turecek, PhD, Friedrich Scheiflinger, PhD, Werner Hoellriegl, DVM, Marietta Putz, MS
Journal: Blood
Blood (2015) 126 (23): 1073.
https://doi.org/10.1182/blood.V126.23.1073.1073
Published: 2015
Journal Articles

Low ADAMTS13 Activity Is a Strong Risk Factor for Ischemic Stroke: A Prospective Cohort Study - the Rotterdam Study

Michelle Alida Helena Sonneveld, MD, Moniek de Maat, PhD, Marileen L.P. Portegies, MD, Albert Hofman, MD PhD, Peter L Turecek, PhD, Hanspeter Rottensteiner, PhD, Friedrich Scheiflinger, PhD, Peter J. Koudstaal, MD PhD, Mohammed A. Ikram, MD PhD, Frank Leebeek, MD PhD
Journal: Blood
Blood (2014) 124 (21): 113.
https://doi.org/10.1182/blood.V124.21.113.113
Published: 2014
Journal Articles

Recombinant VWF Promotes Platelet Adhesion Under Shear Stress Dependent on Its Multimer Size

Gerald Schrenk, PhD, Jutta Schreiner, Herbert Gritsch, Peter L Turecek, PhD, Michael Dockal, PhD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2014) 124 (21): 1442.
https://doi.org/10.1182/blood.V124.21.1442.1442
Published: 2014
Journal Articles

Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial

Clinical Trials & Observations
Pier Mannuccio Mannucci, Christine Kempton, Carolyn Millar, Edward Romond, Amy Shapiro, Ingvild Birschmann, Margaret V. Ragni, Joan Cox Gill, Thynn Thynn Yee, Robert Klamroth, Wing-Yen Wong, Miranda Chapman, Werner Engl, Peter L. Turecek, Tobias M. Suiter, Bruce M. Ewenstein
Journal: Blood
Blood (2013) 122 (5): 648–657.
https://doi.org/10.1182/blood-2013-01-479527
Published: 2013
Includes: Supplemental data
Journal Articles

Importance of Measuring Circulating ADAMTS13 Immune Complexes in Addition to Free Antibodies in Patients with Acquired TTP

Silvia Ferrari, PhD, Barbara Plaimauer, PhD, Bernadette Gruber, Kristina Palavra, Peter L Turecek, PhD, Hartmut J. Ehrlich, MD, Hanspeter Rottensteiner, PhD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2012) 120 (21): 102.
https://doi.org/10.1182/blood.V120.21.102.102
Published: 2012
Journal Articles

Impact of Factor IXa Content On Function, Safety and Efficacy of Recombinant Factor IX Products.

Wilfried Auer, PhD, Hanspeter Rottensteiner, PhD, Gerald Schrenk, PhD, Werner Hoellriegl, PhD, Alexandra Schiviz, DVM, Friedrich Scheiflinger, PhD, Hans Peter Schwarz, MD, Peter L Turecek, PhD, Eva-Maria Muchitsch, PhD
Journal: Blood
Blood (2012) 120 (21): 2233.
https://doi.org/10.1182/blood.V120.21.2233.2233
Published: 2012
Journal Articles

Functional Characterization of Baxter's Recombinant Human ADAMTS13 Drug Candidate.

Hanspeter Rottensteiner, PhD, Barbara Plaimauer, PhD, Gerald Schrenk, PhD, Michaela Schmidt, Bernadette Gruber, Jutta Schreiner, Peter L Turecek, PhD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2012) 120 (21): 2235.
https://doi.org/10.1182/blood.V120.21.2235.2235
Published: 2012
Journal Articles

Structural Characterization of Baxter's Recombinant Human ADAMTS13 Drug Candidate.

Alexandra Foettinger-Vacha, Martin Kaliwoda, PhD, Peter Matthiessen, PhD, Meinhard Hasslacher, PhD, Hanspeter Rottensteiner, PhD, Peter L Turecek, PhD, Artur Mitterer, PhD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2012) 120 (21): 2236.
https://doi.org/10.1182/blood.V120.21.2236.2236
Published: 2012
Journal Articles

The Biological Efficacy Profile of a Chemically Modified Recombinant Factor VIII Molecule,

Leonard A. Valentino, MD, FAAP, Narine Hakobyan, PhD, Candace Enockson, MA, Lin Cong, MD, Friedrich Scheiflinger, PhD, Eva M Muchitsch, PhD, Peter L Turecek, PhD
Journal: Blood
Blood (2011) 118 (21): 3324.
https://doi.org/10.1182/blood.V118.21.3324.3324
Published: 2011
Journal Articles

Detection of Non Inhibitory Binding Antibodies to Von Willebrand Factor Affecting the Clearance of VWF:Ag in Von Willebrand Disease

Tobias M Suiter, MD, Pier Mannuccio Mannucci, MD, Christine L Kempton, MD, MSc, Michael Laffan, MD, Edward H Romond, MD, Amy D. Shapiro, MD, Ingvild Birschmann, MD, PhD, Margaret V. Ragni, MD, MPH, Joan Cox Gill, MD, Thynn Thynn Yee, MD, MSc, FRCP, Robert Klamroth, MD, PhD, Frank M Horling, PhD, Birgit M Reipert, PhD, Peter L Turecek, PhD, Katalin Varadi, PhD, Miranda Chapman, Werner Engl, PhD, Wing Yen Wong, MD, Bruce M. Ewenstein, MD PhD, rhVWF Study Team
Journal: Blood
Blood (2011) 118 (21): 2275.
https://doi.org/10.1182/blood.V118.21.2275.2275
Published: 2011
Journal Articles

Pharmacokinetics of Baxter’s Longer Acting rFVIII (BAX 855) in Factor VIII Ko Mice, Rats and Cynomolgus Monkeys

Gerald Hoebarth, DVM, Susan Kubik, BSc, Martin Wolfsegger, PhD, John-Philip Lawo, Alfred Weber, PhD, Herbert Gritsch, Werner Hoellriegl, Alexandra Schiviz, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD, Peter L Turecek, PhD, Hans Peter Schwarz, MD, Eva-Maria Muchitsch
Journal: Blood
Blood (2011) 118 (21): 4346.
https://doi.org/10.1182/blood.V118.21.4346.4346
Published: 2011
Journal Articles

Efficacy of Baxter’s Longer Acting rFVIII (BAX 855) in Mouse Models of Hemophilia A

Alexandra Schiviz, Eder Barbara, John-Philip Lawo, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD, Peter L Turecek, PhD, Hans Peter Schwarz, MD, Eva-Maria Muchitsch, Werner Hoellriegl
Journal: Blood
Blood (2011) 118 (21): 4350.
https://doi.org/10.1182/blood.V118.21.4350.4350
Published: 2011
Journal Articles

Structural Characterization of BAX 855, a PEGylated Recombinant FVIII

Martin Kaliwoda, PhD, Michael Graninger, PhD, Peter Matthiessen, PhD, Gerald Schrenk, PhD, Peter L Turecek, PhD, Artur Mitterer, PhD, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2011) 118 (21): 4356.
https://doi.org/10.1182/blood.V118.21.4356.4356
Published: 2011
Journal Articles

Absorption, Metabolism, Distribution, and Excretion of Longer Acting rFVIII (BAX 855) Following Intravenous Administration to Rats

Reinhard Stidl, PhD, Juergen Siekmann, PhD, Sean M Culbertson, Tony Vinson, Antoni Kozlowski, Xiaoming Shen, Mary J Bossard, Hanspeter Rottensteiner, PhD, Barbara Dietrich, DVM, Chyung Cook, Peter L Turecek, PhD, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD, Hans Peter Schwarz, MD, Eva-Maria Muchitsch
Journal: Blood
Blood (2011) 118 (21): 4358.
https://doi.org/10.1182/blood.V118.21.4358.4358
Published: 2011